The current literature on hormone receptor expression in adenomyosis lesions and eutopic endometrium is constrained by technical variations and insufficient consideration of known differences that are related to menstrual cycle phases or endometrial subregions. This evidence concerns the gene NR4A1 and adenomyosis.